Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles.

Autor: Sánchez-Juan P; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Research Platforms, 28031 Madrid, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, 28029 Madrid, Spain., Valeriano-Lorenzo E; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Research Platforms, 28031 Madrid, Spain., Ruiz-González A; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Research Platforms, 28031 Madrid, Spain., Pastor AB; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Research Platforms, 28031 Madrid, Spain., Rodrigo Lara H; Banco de Cerebros de la Región de Murcia, Neuropathology Department, 30120 Murcia, Spain., López-González F; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Research Platforms, 28031 Madrid, Spain., Zea-Sevilla MA; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Research Platforms, 28031 Madrid, Spain., Valentí M; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Research Platforms, 28031 Madrid, Spain., Frades B; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Research Platforms, 28031 Madrid, Spain., Ruiz P; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Research Platforms, 28031 Madrid, Spain., Saiz L; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Research Platforms, 28031 Madrid, Spain., Burgueño-García I; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Research Platforms, 28031 Madrid, Spain., Calero M; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Research Platforms, 28031 Madrid, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, 28029 Madrid, Spain.; Chronic Disease Programme, Instituto de Salud Carlos III, Madrid, Spain., Del Ser T; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Research Platforms, 28031 Madrid, Spain., Rábano A; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Research Platforms, 28031 Madrid, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, 28029 Madrid, Spain.

Publikováno v: Brain : a journal of neurology [Brain] 2024 May 03; Vol. 147 (5), pp. 1667-1679.

21030. RELACIÓN ENTRE PATOLOGÍA NEURODEGENERATIVA MÚLTIPLE Y EL ESTADO COGNITIVO Y FUNCIONAL

Autor: Frades Payo, M., Valeriano Lorenzo, E., López Martínez, M., Rábano, A., Sánchez Juan, P., del Ser Quijano, T.

Publikováno v: In Neurology Perspectives November 2024 4 Supplement 1:179-180

21628. ¿IMPACTA LA PATOLOGÍA NEURODEGENERATIVA MÚLTIPLE EN EL COMPORTAMIENTO DE BIOMARCADORES EN SANGRE?

Autor: Valeriano Lorenzo, E., Rábano, A., Wagner, S., Ruiz, A., Pastor, A., Valentí, M., Riccardi, M., Zea Sevilla, M., Frades, B., Antón, M., Saiz Auz, L., Burgueño, I., López Martínez, M., del Ser, T., Sánchez Juan, P.

Publikováno v: In Neurology Perspectives November 2024 4 Supplement 1:21-21

Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects.

Autor: Martínez-Dubarbie F; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain., López-García S; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain., Lage C; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.; Atlantic Fellow for Equity in Brain health, Global Brain Health Institute, University of California, San Francisco, CA, USA., Di Molfetta G; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden., Fernández-Matarrubia M; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain., Pozueta-Cantudo A; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain., García-Martínez M; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain., Corrales-Pardo A; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain., Bravo M; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain., Jiménez-Bonilla J; Nuclear Medicine Department, Marqués de Valdecilla University Hospital, University of Cantabria and Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain., Quirce R; Nuclear Medicine Department, Marqués de Valdecilla University Hospital, University of Cantabria and Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain., Marco de Lucas E; Radiology Department, Marqués de Valdecilla University Hospital, Santander, Spain., Drake-Pérez M; Radiology Department, Marqués de Valdecilla University Hospital, Santander, Spain., Tordesillas D; Radiology Department, Marqués de Valdecilla University Hospital, Santander, Spain., López-Hoyos M; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.; Immunology Department, Marqués de Valdecilla University Hospital, Santander, Spain., Irure-Ventura J; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.; Immunology Department, Marqués de Valdecilla University Hospital, Santander, Spain., Valeriano-Lorenzo E; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Madrid, Spain., Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden., Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.; King's College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute, London, UK.; NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, UK., Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA., Rodríguez-Rodríguez E; Neurology Service, Marqués de Valdecilla University Hospital, Santander, Spain.; Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain., Sánchez-Juan P; Alzheimer's Centre Reina Sofia-CIEN Foundation-ISCIII, Madrid, Spain.; CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.

Publikováno v: Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2024; Vol. 98 (3), pp. 1029-1042.

Dimensions of cognitive reserve and their predictive power of cognitive performance and decline in the elderly.

Autor: Del Ser T; Clinical Department, Alzheimer's Center Reina Sofia-CIEN Foundation, Madrid, Spain., Valeriano-Lorenzo E; Clinical Department, Alzheimer's Center Reina Sofia-CIEN Foundation, Madrid, Spain., Jáñez-Escalada L; Clinical Department, Alzheimer's Center Reina Sofia-CIEN Foundation, Madrid, Spain.; Institute of Knowledge Technology, Complutense University, Madrid, Spain., Ávila-Villanueva M; Clinical Department, Alzheimer's Center Reina Sofia-CIEN Foundation, Madrid, Spain., Frades B; Clinical Department, Alzheimer's Center Reina Sofia-CIEN Foundation, Madrid, Spain., Zea MA; Clinical Department, Alzheimer's Center Reina Sofia-CIEN Foundation, Madrid, Spain., Valentí M; Clinical Department, Alzheimer's Center Reina Sofia-CIEN Foundation, Madrid, Spain., Zhang L; Neuroimaging Department, Alzheimer's Center Reina Sofia-CIEN Foundation, Madrid, Spain., Fernández-Blázquez MA; Clinical Department, Alzheimer's Center Reina Sofia-CIEN Foundation, Madrid, Spain.

Publikováno v: Frontiers in dementia [Front Dement] 2023 Aug 31; Vol. 2, pp. 1099059. Date of Electronic Publication: 2023 Aug 31 (Print Publication: 2023).